VSTM

Verastem, Inc. VSTM

VSTM
Verastem, Inc. VRCA
Verrica Pharmaceuticals Inc. TERN
Terns Pharmaceuticals, Inc. NAUT
Nautilus Biotechnology, Inc. OMER
Omeros Corporation VKTX
Viking Therapeutics, Inc. TRVN
Trevena, Inc. KPTI
Karyopharm Therapeutics Inc. TLPH
Talphera, Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode VSTM VRCA TERN NAUT OMER VKTX TRVN KPTI TLPH
6M 84.70 % -14.46 % 280.84 % 7.53 % -37.74 % 51.04 % -98.94 % 28.21 % 146.00 %
YTD 32.05 % -41.11 % 43.74 % -49.67 % -57.42 % -18.39 % -99.25 % -54.81 % 108.44 %
1Y 185.67 % -70.85 % 6.96 % -69.84 % 5.54 % -49.00 % -99.39 % -56.86 % 58.30 %
3Y 74.19 % -82.82 % 23.48 % -58.10 % 25.83 % 1 007.59 % -99.99 % -92.82 % -69.25 %
5Y -46.70 % -95.22 % -55.68 % -92.03 % -62.52 % 455.63 % -100.00 % -97.57 % -96.89 %
10Y -62.01 % -97.63 % -55.68 % -91.85 % -64.85 % 388.50 % -100.00 % -96.83 % -98.31 %
From the beginning -93.56 % -97.63 % -55.68 % -91.85 % -52.00 % 319.50 % -100.00 % -97.71 % -98.65 %

Dividend